Comorbid anxiety, depression, and cognition in MS and other immune-mediated disorders
Article 2019 en
Authors
CW
Christiane E. Whitehouse
JF
John D. Fisk
ÇB
Çharles N. Bernstein
Abstract
1 min read
Anxiety and depression are associated with lower cognitive function in MS, with a similar pattern observed in persons with other IMID, including IBD and RA, and persons without an IMID. Managing symptoms of anxiety and of depression in MS, as well as other IMIDs, is important to mitigate their effect on cognition.
Ruth Ann Marrie, Randy Walld, James M. Bolton, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, James Marriott, Renée El‐Gabalawy, Alan Katz, John D. Fisk, Çharles N. Bernstein
Shaza Almweisheer, Çharles N. Bernstein, Lesley A. Graff, Scott Burton Patten, James M. Bolton, John D. Fisk, Carol Hitchon, James Marriott, Ruth Ann Marrie
Ruth Ann Marrie, Randy Walld, James M. Bolton, Jitender Sareen, Scott Burton Patten, Alexander Singer, Lisa M. Lix, Carol Hitchon, Renée El‐Gabalawy, Alan Katz, John D. Fisk, Çharles N. Bernstein
Çharles N. Bernstein, Lixia Zhang, Lisa M. Lix, Lesley A. Graff, John R. Walker, John D. Fisk, Scott Burton Patten, Carol Hitchon, James M. Bolton, Jitender Sareen, Renée El‐Gabalawy, James Marriott, Ruth Ann Marrie
Discussion(0)
No comments yet. Be the first to comment.